TDP-43 Proteinopathies clinical trials at UC Irvine
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
The CENTAUR trial will be a 2:1 (active:placebo) randomized, double-blind, placebo-controlled Phase II trial to evaluate the safety and efficacy of AMX0035 for the treatment of ALS.
Orange, California and other locations